圣达生物
(603079)
| 流通市值：23.31亿 | | | 总市值：23.31亿 |
| 流通股本：1.89亿 | | | 总股本：1.89亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 389,057,542.5 | 189,216,336.68 | 844,536,869.9 | 621,284,743.25 |
| 营业总成本 | 358,794,109.64 | 171,919,634.54 | 764,169,196.49 | 555,173,218.95 |
| 其他经营收益 | | | | |
| 营业利润 | 33,154,446.69 | 18,576,944.25 | 80,214,011.27 | 72,240,018.7 |
| 利润总额 | 31,881,661.12 | 18,582,178.68 | 80,127,337.04 | 72,099,519.99 |
| 净利润 | 24,521,575.34 | 15,313,732.57 | 69,264,339.67 | 58,727,071.15 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 24,521,575.34 | 15,313,732.57 | 69,264,339.67 | 58,727,071.15 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,048,239,755.57 | 986,411,965.27 | 1,010,409,629.49 | 960,694,846.93 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,219,005,571.26 | 1,206,102,932.77 | 1,188,140,324.19 | 1,185,576,800.03 |
| 资产总计 | 2,267,245,326.83 | 2,192,514,898.04 | 2,198,549,953.68 | 2,146,271,646.96 |
| 流动负债: | | | | |
| 流动负债合计 | 294,742,626.19 | 210,467,110.12 | 246,699,759.61 | 218,090,915.38 |
| 非流动负债: | | | | |
| 非流动负债合计 | 350,813,797.44 | 351,504,939.59 | 337,050,008.94 | 324,055,994.97 |
| 负债合计 | 645,556,423.63 | 561,972,049.71 | 583,749,768.55 | 542,146,910.35 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,587,443,566.41 | 1,598,152,508.72 | 1,584,548,889.12 | 1,575,593,555.27 |
| 股东权益合计 | 1,621,688,903.2 | 1,630,542,848.33 | 1,614,800,185.13 | 1,604,124,736.61 |
| 负债和股东权益合计 | 2,267,245,326.83 | 2,192,514,898.04 | 2,198,549,953.68 | 2,146,271,646.96 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 440,427,680.61 | 237,235,762.17 | 903,448,231.83 | 677,952,863.68 |
| 经营活动现金流出小计 | 429,699,152.7 | 240,459,387.33 | 764,563,679.95 | 610,287,985.97 |
| 经营活动产生的现金流量净额 | 10,728,527.91 | -3,223,625.16 | 138,884,551.88 | 67,664,877.71 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 786,188,901.83 | 451,780,357.44 | 1,375,485,175.48 | 1,043,836,025.93 |
| 投资活动现金流出小计 | 671,154,666.73 | 326,214,237.31 | 1,692,691,164.36 | 1,154,312,964.88 |
| 投资活动产生的现金流量净额 | 115,034,235.1 | 125,566,120.13 | -317,205,988.88 | -110,476,938.95 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 17,000,000 | 13,000,000 | 408,379,190 | 388,029,990 |
| 筹资活动现金流出小计 | 17,381,286.38 | 4,507,480.72 | 89,309,332.72 | 86,736,664.08 |
| 筹资活动产生的现金流量净额 | -381,286.38 | 8,492,519.28 | 319,069,857.28 | 301,293,325.92 |
| 汇率变动对现金及现金等价物的影响 | -6,211,144.51 | -3,083,736.08 | -1,487,249.35 | 9,278 |
| 现金及现金等价物净增加额 | 119,170,332.12 | 127,751,278.17 | 139,261,170.93 | 258,490,542.68 |
| 期末现金及现金等价物余额 | 521,940,100.37 | 530,521,046.42 | 402,769,768.25 | 521,999,140 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 119,170,332.12 | - | 139,261,170.93 | - |